Literature DB >> 15720998

A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.

Sarmela Thevarajah1, Tara L Huston, Rache M Simmons.   

Abstract

BACKGROUND: Sentinel lymph node biopsy (SLNB) is an established means of staging the axilla in patients with breast cancer. Recently, methylene blue dye has been shown to be an efficacious and cost-effective alternative to isosulfan blue. With the increasing popularity of SLNB, the potential complications of isosulfan blue use must be appreciated.
METHODS: A literature search for English language articles available on MEDLINE from 1985 to November 2002 using the search terms allergy, allergic reaction, anaphylactic reactions, anaphylaxis, blue dye, breast cancer, isosulfan blue, methylene blue, and sentinel lymph node biopsy identified 24 reports.
CONCLUSIONS: The use of isosulfan blue due for SLNB is associated with a significant number of allergic reactions, some of which are life-threatening. Because methylene blue dye has been shown to be equally effective and does not pose a serious risk of serious allergic reactions, it offers an improved technique above isosulfan blue dye for SLNB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720998     DOI: 10.1016/j.amjsurg.2004.06.042

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  36 in total

1.  Dyed but not dead.

Authors:  Shireen H Haque; Bobby D Nossaman
Journal:  Ochsner J       Date:  2012

2.  Hands-free, wireless goggles for near-infrared fluorescence and real-time image-guided surgery.

Authors:  Yang Liu; Adam Q Bauer; Walter J Akers; Gail Sudlow; Kexian Liang; Duanwen Shen; Mikhail Y Berezin; Joseph P Culver; Samuel Achilefu
Journal:  Surgery       Date:  2011-05       Impact factor: 3.982

3.  Comparison of ex vivo and in vivo injection of blue dye in sentinel lymph node mapping for colorectal cancer.

Authors:  Jun Seok Park; In Taik Chang; Sung Jun Park; Beom Gyu Kim; Yoo Shin Choi; Seong Jae Cha; Eon Sub Park; Gui Young Kwon
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

Review 4.  Management of nodal disease from colon cancer in the laparoscopic era.

Authors:  Corrado Pedrazzani; Lelde Lauka; Simone Sforza; Andrea Ruzzenente; Filippo Nifosì; GianGaetano Delaini; Alfredo Guglielmi
Journal:  Int J Colorectal Dis       Date:  2014-11-22       Impact factor: 2.571

Review 5.  Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation.

Authors:  Madeline T Olson; Quan P Ly; Aaron M Mohs
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

6.  How long will I be blue? Prolonged skin staining following sentinel lymph node biopsy using intradermal patent blue dye.

Authors:  Metehan Gumus; Hatice Gumus; Sue E Jones; Peter A Jones; Ali R Sever; Jennifer Weeks
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

7.  A phase I/II trial of 125I methylene blue for one-stage sentinel lymph node biopsy.

Authors:  Jason David Cundiff; Yi-Zarn Wang; Gregory Espenan; Thomas Maloney; Arthur Camp; Laura Lazarus; Alan Stolier; Randy Brooks; Bruce Torrance; Shawn Stafford; James P O'Leary; Eugene A Woltering
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

8.  Evaluation of a skin testing protocol for diagnosing perioperative anaphylaxis due to isosulfan blue allergy.

Authors:  Mary Grace Baker; Julia A Cronin; Larry Borish; Monica G Lawrence
Journal:  Ann Allergy Asthma Immunol       Date:  2014-08-03       Impact factor: 6.347

9.  Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.

Authors:  Ted A James; Alex R Coffman; Anees B Chagpar; Judy C Boughey; V Suzanne Klimberg; Monica Morrow; Armando E Giuliano; Seth P Harlow
Journal:  Ann Surg Oncol       Date:  2016-07-21       Impact factor: 5.344

10.  Adverse reaction; patent blue turning patient blue.

Authors:  Meera Joshi; Matthew Hart; Farid Ahmed; Sandy McPherson
Journal:  BMJ Case Rep       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.